Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Investor suits against AbbVie pile up in wake of Humira kickback allegations
Fierce Pharma
Thu, 10/11/18 - 12:05 pm
Tags:
AbbVie, Humira, Class Action Lawsuit
AbbVie's not the only one facing kickbacks scrutiny. Add Biogen, Sanofi, Gilead and more
Fierce Pharma
Tue, 09/25/18 - 07:19 pm
Tags:
AbbVie, Biogen, Sanofi, Gilead Sciences
Unwanted by AbbVie and Infinity, battered Verastem gets an OK for duvelisib and a second shot at success
Endpoints
Mon, 09/24/18 - 08:26 pm
Tags:
Verastem, AbbVie, Infinity Pharmaceuticals, duvelisib
Following AbbVie Lawsuit, Government Scrutinizes Industry-Provided Drug Educational Support Services
BioSpace
Sun, 09/23/18 - 10:28 pm
Tags:
AbbVie
Release: AbbVie Announces $5 Million Donation to Family Reach to Support Children Battling Cancer and Their Families
BioSpace
Sat, 09/22/18 - 05:35 pm
Tags:
AbbVie, cancer, pediatric cancer, philanthropy
5th Humira biosimilar approved in EU as market entry nears
Biopharma Dive
Fri, 09/21/18 - 12:06 am
Tags:
Europe, biosimilars, AbbVie, Humira, Mylan, Hulio
Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie
Forbes
Thu, 09/20/18 - 11:50 am
Tags:
AbbVie, Mylan Labs, Fujifilm, biosimilars, Humira
In kickbacks case, CA insurance chief says AbbVie used nurse 'ambassadors' to protect Humira sales
Fierce Pharma
Tue, 09/18/18 - 10:45 pm
Tags:
kickbacks, AbbVie, physicians, Humira
Pharma/Biotech Stocks to Watch This Prostate Cancer Month
Yahoo/Zacks.com
Sun, 09/16/18 - 02:16 pm
Tags:
prostate cancer, JNJ, Zytiga, Erleada, Pfizer, Astellas, Xtandi, AbbVie, Lupron, Endocyte, Lu-PSMA-617
A Brawl Is Brewing Between AbbVie and Gilead Sciences in Arthritis
Yahoo/Motley Fool
Fri, 09/14/18 - 09:36 am
Tags:
AbbVie, Gilead Sciences, FDA, rheumatoid arthritis, Upadacitinib, filgotinib
Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira
CP Wire
Wed, 09/12/18 - 11:08 am
Tags:
Janssen Pharmaceuticals, JNJ, chronic plaque psoriasis, Tremfya, Humira, AbbVie, clinical trials
AbbVie strikes tentative deal to settle 4,000-plus AndroGel lawsuits
Fierce Pharma
Tue, 09/11/18 - 11:48 am
Tags:
AbbVie, Androgel
AbbVie braces for impact of Humira biosimilars in Europe
Pharmaforum
Thu, 08/30/18 - 08:28 pm
Tags:
AbbVie, Humira, Europe, biosimilars
Jumping ahead of AstraZeneca, AbbVie and J&J get a green light to market Imbruvica/Rituxan combo for rare lymphoma
Endpoints
Mon, 08/27/18 - 10:02 am
Tags:
AbbVie, JNJ, FDA, Imbruvica, Rituxan, Roche, AstraZeneca, non-Hodgkin's lymphoma, Waldenström’s macroglobulinemia
AbbVie extension study tees up elagolix for uterine fibroids
Biopharma Dive
Thu, 08/23/18 - 04:30 pm
Tags:
AbbVie, uterine fibroids, Elagolix, clinical trials
AbbVie's Trump tax rate cut—biggest in pharma—yields another $100M donation
Fierce Pharma
Wed, 08/22/18 - 11:43 am
Tags:
AbbVie, charity, tax cuts, donations
AbbVie doubles down on cancer project with biotech group Argenx
Yahoo/Reuters
Wed, 08/22/18 - 09:49 am
Tags:
Argenx, AbbVie, ARGX-115, cancer immunotherapy
AbbVie, Tolero to collaborate on acute myeloid leukemia trial
Pharmaceutical Business Review
Mon, 08/20/18 - 10:44 pm
Tags:
AbbVie, Tolero Pharmaceuticals, AML, venetoclax, alvocidib
AbbVie, Sanofi-backed Principia offers an $86M IPO after burning through $148M for pipeline work
Endpoints
Mon, 08/20/18 - 10:11 am
Tags:
IPOs, Principia Biopharma, Sanofi, AbbVie, PRN1008, autoimmune disease
AbbVie, Tolero team up to test Venclexta combo in AML
Fierce Biotech
Sat, 08/18/18 - 05:09 pm
Tags:
AbbVie, Tolero Pharmaceuticals, Venclexta, alvocidib, AML

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.